Literature DB >> 22974391

Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue.

Jennifer A Fairley1, Katelyn Gilmour, Kathy Walsh.   

Abstract

The development of commercial reagents designed specifically for use with formalin-fixed paraffin-embedded (FFPE) tissue has unlocked the diagnostic potential of this prolific resource. The availability of archival FFPE tissue and tissue from current patients make it an ideal resource for molecular testing. Despite its stability and ability to preserve morphological information, FFPE provides a number of technical challenges to the study of biomolecules. In particular, the cross-linking and processing present problems in the extraction and isolation of DNA, RNA and protein and affect their use in downstream analysis. Here we will discuss some of the problems of FFPE tissue, how they can be overcome and how FFPE material can be used within clinical molecular diagnostics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22974391     DOI: 10.2174/138945012803530125

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  8 in total

Review 1.  Translating next generation sequencing to practice: opportunities and necessary steps.

Authors:  Sitharthan Kamalakaran; Vinay Varadan; Angel Janevski; Nilanjana Banerjee; David Tuck; W Richard McCombie; Nevenka Dimitrova; Lyndsay N Harris
Journal:  Mol Oncol       Date:  2013-05-15       Impact factor: 6.603

2.  Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application schedule.

Authors:  Michael Dobosz; Ute Haupt; Werner Scheuer
Journal:  MAbs       Date:  2016-09-23       Impact factor: 5.857

Review 3.  The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings.

Authors:  Maryam Shabihkhani; Gregory M Lucey; Bowen Wei; Sergey Mareninov; Jerry J Lou; Harry V Vinters; Elyse J Singer; Timothy F Cloughesy; William H Yong
Journal:  Clin Biochem       Date:  2014-01-12       Impact factor: 3.281

Review 4.  Drug discovery in advanced prostate cancer: translating biology into therapy.

Authors:  Timothy A Yap; Alan D Smith; Roberta Ferraldeschi; Bissan Al-Lazikani; Paul Workman; Johann S de Bono
Journal:  Nat Rev Drug Discov       Date:  2016-07-22       Impact factor: 84.694

5.  Organocatalytic removal of formaldehyde adducts from RNA and DNA bases.

Authors:  Saswata Karmakar; Emily M Harcourt; David S Hewings; Florian Scherer; Alexander F Lovejoy; David M Kurtz; Thomas Ehrenschwender; Luzi J Barandun; Caroline Roost; Ash A Alizadeh; Eric T Kool
Journal:  Nat Chem       Date:  2015-08-03       Impact factor: 24.427

Review 6.  Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics.

Authors:  Saumya Pant; Russell Weiner; Matthew J Marton
Journal:  Front Oncol       Date:  2014-04-17       Impact factor: 6.244

7.  Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens.

Authors:  Jing Song; Weili Du; Zichen Liu; Jialu Che; Kun Li; Nanying Che
Journal:  Microbiol Spectr       Date:  2022-02-09

8.  Biobanking informatics infrastructure to support clinical and translational research.

Authors:  Bernie Lasalle; Michael Varner; Jeff Botkin; Marc Jackson; Louisa Stark; Melissa Cessna; Carolyn Orthner; Nathan Hulse; Aldo Bernasconi; Randy Madsen; Dustin Schultz; Richard Bradshaw; Joyce Mitchell
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2013-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.